High Growth Tech Stocks Featuring Sangfor Technologies And Two Others

Mar 31, 2025
high-growth-tech-stocks-featuring-sangfor-technologies-and-two-others

Unlock stock picks and a broker-level newsfeed that powers Wall Street.

editorial-team@simplywallst.com (Simply Wall St)

4 min read

In This Article:

Amidst economic uncertainty and inflation fears, global markets have been under pressure, with U.S. stock indexes declining due to trade policy concerns and persistent inflation impacting growth shares. In this challenging environment, identifying high-growth tech stocks that can navigate these headwinds is crucial for investors seeking potential opportunities in the tech sector.

Name

Revenue Growth

Earnings Growth

Growth Rating

eWeLLLtd

24.65%

25.30%

★★★★★★

Pharma Mar

24.24%

40.82%

★★★★★★

Seojin SystemLtd

31.68%

39.34%

★★★★★★

Elicera Therapeutics

63.53%

97.24%

★★★★★★

Elliptic Laboratories

49.76%

88.21%

★★★★★★

Ascelia Pharma

46.09%

66.93%

★★★★★★

CD Projekt

33.68%

36.76%

★★★★★★

JNTC

28.84%

104.08%

★★★★★★

Ascentage Pharma Group International

23.93%

83.57%

★★★★★★

Delton Technology (Guangzhou)

20.25%

29.52%

★★★★★★

Click here to see the full list of 786 stocks from our Global High Growth Tech and AI Stocks screener.

Let’s explore several standout options from the results in the screener.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Sangfor Technologies Inc. offers IT infrastructure solutions both in China and globally, with a market capitalization of CN¥42.97 billion.

Operations: Sangfor Technologies Inc. specializes in IT infrastructure solutions, serving both domestic and international markets. The company’s revenue streams are primarily derived from its comprehensive range of products and services designed to enhance IT efficiency and security.

Sangfor Technologies has demonstrated resilience with a reported annual revenue of CNY 7.52 billion, slightly down from CNY 7.66 billion the previous year, yet maintaining consistent earnings per share at CNY 0.47. The firm’s commitment to innovation is evident in its strategic allocation of funds towards share repurchases valued at CNY 200 million, aimed at bolstering employee ownership plans—a move that underscores confidence in its operational stability and future growth prospects. Additionally, Sangfor’s projected earnings growth rate of 28.9% annually outpaces the broader Chinese market’s forecast of 24.8%, signaling robust potential despite a highly volatile share price in recent months.

SZSE:300454 Revenue and Expenses Breakdown as at Mar 2025

SZSE:300454 Revenue and Expenses Breakdown as at Mar 2025

Simply Wall St Growth Rating: ★★★★★☆

Overview: Empyrean Technology Co., Ltd. specializes in the development, sale, and servicing of electronic design automation (EDA) software and has a market capitalization of CN¥60.55 billion.


Leave a comment